CT SB00019

Health carriers must issue electronic authorization to pharmacies for temporary drug supplies during prospective review requests for chronic disease medications (excluding schedule II or III controlled substances) prescribed by specialist providers while the review is pending.

The temporary drug supply authorization must be sufficient to cover the duration of the review and include confirmation that payment is available.

Within 24 hours of issuing the authorization and before the pharmacy dispenses the drug, the health carrier must confirm with the prescribing provider that they concur with dispensing the temporary supply; if the provider does not concur, the carrier must cancel the authorization.

These requirements apply to both standard prospective review requests under section 38a-591d and expedited grievance reviews of prospective requests under section 38a-591e.

Effective date: January 1, 2018.